Group One Trading
AMRI

Group One Trading’s Albany Molecular Research Inc AMRI Stock Holding History

Group One Trading’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-18,203
Closed -$395K – 5503
2017
Q2 		$395K Buy
+18,203
New +$330K ﹤0.01% 2144
2016
Q4 		– Sell
-10,084
Closed -$166K – 5138
2016
Q3 		$166K Sell
10,084
-39,000
-79% -$578K ﹤0.01% 2608
2016
Q2 		$660K Buy
49,084
+17,943
+58% +$262K 0.01% 1540
2016
Q1 		$476K Buy
+31,141
New +$488K 0.01% 1723
2015
Q2 		– Sell
-6,382
Closed -$112K – 5429
2015
Q1 		$112K Sell
6,382
-6,300
-50% -$107K ﹤0.01% 2830
2014
Q4 		$206K Buy
12,682
+2,703
+27% +$49.6K ﹤0.01% 2288
2014
Q3 		$220K Buy
9,979
+8,864
+795% +$182K ﹤0.01% 2300
2014
Q2 		$22K Buy
+1,115
New +$18.9K ﹤0.01% 4111
2013
Q4 		– Sell
-6,917
Closed -$89K – 5742
2013
Q3 		$89K Sell
6,917
-7,000
-50% -$86.1K ﹤0.01% 3125
2013
Q2 		$165K Buy
+13,917
New +$151K ﹤0.01% 2352

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Group One Trading's AMRI Position: Q3 2017 in Review

Group One Trading sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 18,203 shares — an estimated $395K sold.

Group One Trading first reported a position in AMRI in Q2 2013 and held it in 10 quarters. The position peaked at $660K in Q2 2016. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • Group One Trading reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • Group One Trading sold 18,203 Albany Molecular Research Inc shares in Q3 2017, an estimated $395K.
  • Group One Trading first reported a position in Albany Molecular Research Inc in Q2 2013 and held it in 10 quarters.
  • Group One Trading's Albany Molecular Research Inc position peaked at $660K in Q2 2016.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Group One Trading's 13F filing for Q3 2017, filed 15 Nov 2017.